Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000893220-08-001225
Filing Date
2008-04-28
Accepted
2008-04-28 12:42:11
Documents
5
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A FOR RPS w55874e10vkza.htm 10-K/A 292055
2 CERTIFICATION PURSUANT TO EXCHANGE ACT RULES 13A-14(A)/15D-14(A), AS ADOPTED PUR w55874exv31w1.htm EX-31.1 7810
3 CERTIFICATION PURSUANT TO EXCHANGE ACT RULES 13A-14(A)/15D-14(A), AS ADOPTED PUR w55874exv31w2.htm EX-31.2 7792
4 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION w55874exv32w1.htm EX-32.1 3478
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION w55874exv32w2.htm EX-32.2 3460
  Complete submission text file 0000893220-08-001225.txt   316033
Mailing Address 520 VIRGINIA DRIVE FORT WASHINGTON PA 19034
Business Address 520 VIRGINIA DRIVE FORT WASHINGTON PA 19034 215-540-0700
RESEARCH PHARMACEUTICAL SERVICES, INC. (Filer) CIK: 0001420070 (see all company filings)

EIN.: 204322769 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-52981 | Film No.: 08780141
SIC: 8731 Services-Commercial Physical & Biological Research